# Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)

> **NCT07427043** · PHASE3 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Opioid Consumption, Postoperative
- Multimodal Analgesia
- Robotic Assisted Laparoscopic Surgery
- Robotic Assisted Laparoscopic Radical Prostatectomy
- Prostate Cancer

## Interventions

- **DRUG:** multimodal analgesia pathway with up-front small opioid prescription
- **DRUG:** multimodal analgesia pathway without up-front small opioid prescription
- **DRUG:** pre-implementation baseline including opioid

## Key facts

- **NCT ID:** NCT07427043
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07427043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07427043, "Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07427043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*